Prognostic Score in Covid-19

Identification of a Clinical Score to Support the Clinician in Phase 2 of Covid-19

NCT04780373•University of L'Aquila

View on ClinicalTrials.gov

AI summary by Clareo Health

Generating AI summary...

Conditions

Covid19 Prognostic Parameters

Interventions

data collection

Locations

Italy

Locations (1)

University of L'Aquila

L’Aquila, Italy

Key Dates

Start Date

April 1, 2020

Primary Completion Date

December 1, 2020

Completion Date

December 1, 2020

Last Updated

April 29, 2021

Sponsors

Lead Sponsor

University of L'Aquila

Full Eligibility Criteria

Data Source & Attribution

This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.

ClinicalTrials.gov last update: April 29, 2021Data synced to Clareo: March 29, 2026

Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.

Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.

View ClinicalTrials.gov Terms and Conditions